Showing results (171-180 of 188) with videos related to
Sort By:
Pageof 19
Trials|April 13, 2021
Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trialNikhil Vergis, Rachel Phillips, Victoria Cornelius, et al.BMJ Open|January 8, 2025
Intestinal Microbiota Transplant Prior to Allogeneic Stem Cell Transplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trialBenjamin H Mullish, Andrew J Innes, Lauren A Roberts, et al.Nature Aging|November 28, 2022
3-deazaadenosine (3DA) alleviates senescence to promote cellular fitness and cell therapy efficiency in miceAna Guerrero, Andrew J Innes, Pierre-François Roux, et al.Frontiers in Cellular and Infection Microbiology|September 13, 2021
Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell TransplantationAndrew J Innes, Benjamin H Mullish, Rohma Ghani, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2026
BCR::ABL1-Induced Enhancer Reprogramming Uncovers Hypersensitivity of Ph+B-ALL Cells to Enhancer-Targeting DrugsHan Leng Ng, Trudy Lee Glaser, Jintao Zhu, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2019
A Multispecies Cluster of GES-5 Carbapenemase-Producing Enterobacterales Linked by a Geographically Disseminated PlasmidMatthew J Ellington, Frances Davies, Elita Jauneikaite, et al.The Lancet. HIV|March 15, 2020
Evidence for HIV-1 cure after CCR5Δ32/Δ32 allogeneic haemopoietic stem-cell transplantation 30 months post analytical treatment interruption: a case reportRavindra Kumar Gupta, Dimitra Peppa, Alison L Hill, et al.Blood Advances|February 27, 2026
Phase 2 study of the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for essential thrombocythemiaHarinder Gill, Francesca Palandri, David M Ross, et al.Nature Reviews. Clinical Oncology|September 1, 2025
Apoptosis-targeting BH3 mimetics: transforming treatment for patients with acute myeloid leukaemiaAntonino Glaviano, Ellen Weisberg, Hiu Y Lam, et al.Nature Metabolism|December 5, 2019
Cardiac glycosides are broad-spectrum senolyticsAna Guerrero, Nicolás Herranz, Bin Sun, et al.Pageof 19